261 related articles for article (PubMed ID: 23838861)
21. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
[TBL] [Abstract][Full Text] [Related]
22. The interaction between BRAF mutation and microsatellite instability (MSI) status in determining survival outcomes after adjuvant 5FU based chemotherapy in stage III colon cancer.
Chouhan H; Sammour T; Thomas ML; Moore JW
J Surg Oncol; 2018 Dec; 118(8):1311-1317. PubMed ID: 30399198
[TBL] [Abstract][Full Text] [Related]
23. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location.
Gervaz P; Bouzourene H; Cerottini JP; Chaubert P; Benhattar J; Secic M; Wexner S; Givel JC; Belin B
Dis Colon Rectum; 2001 Mar; 44(3):364-72; discussion 372-3. PubMed ID: 11289282
[TBL] [Abstract][Full Text] [Related]
24. Colon Cancer Tumor Location Defined by Gene Expression May Disagree With Anatomic Tumor Location.
Cannon E; Buechler S
Clin Colorectal Cancer; 2019 Jun; 18(2):149-158. PubMed ID: 30853326
[TBL] [Abstract][Full Text] [Related]
25. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer.
Newcomb PA; Baron J; Cotterchio M; Gallinger S; Grove J; Haile R; Hall D; Hopper JL; Jass J; Le Marchand L; Limburg P; Lindor N; Potter JD; Templeton AS; Thibodeau S; Seminara D;
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2331-43. PubMed ID: 17982118
[TBL] [Abstract][Full Text] [Related]
26. CIMP status of interval colon cancers: another piece to the puzzle.
Arain MA; Sawhney M; Sheikh S; Anway R; Thyagarajan B; Bond JH; Shaukat A
Am J Gastroenterol; 2010 May; 105(5):1189-95. PubMed ID: 20010923
[TBL] [Abstract][Full Text] [Related]
27. Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles.
Minoo P; Zlobec I; Peterson M; Terracciano L; Lugli A
Int J Oncol; 2010 Sep; 37(3):707-18. PubMed ID: 20664940
[TBL] [Abstract][Full Text] [Related]
28. [Insights on colorectal carcinoma based on the biological differences between left-sided and right- sided colon cancers].
Xu JM
Zhonghua Zhong Liu Za Zhi; 2016 May; 38(5):397-400. PubMed ID: 27188617
[TBL] [Abstract][Full Text] [Related]
29. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
30. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.
Deschoolmeester V; Van Damme N; Baay M; Claes K; Van Marck E; Baert FJ; Wuyts W; Cabooter M; Weyler J; Vermeulen P; Lardon F; Vermorken JB; Peeters M
Eur J Cancer; 2008 Oct; 44(15):2288-95. PubMed ID: 18707864
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.
Barault L; Charon-Barra C; Jooste V; de la Vega MF; Martin L; Roignot P; Rat P; Bouvier AM; Laurent-Puig P; Faivre J; Chapusot C; Piard F
Cancer Res; 2008 Oct; 68(20):8541-6. PubMed ID: 18922929
[TBL] [Abstract][Full Text] [Related]
32. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
[TBL] [Abstract][Full Text] [Related]
33. A Changing Spectrum of Colorectal Cancer Biology With Age: Implications for the Young Patient.
Chouhan H; Ferrandon S; DeVecchio J; Kalady MF; Church JM
Dis Colon Rectum; 2019 Jan; 62(1):21-26. PubMed ID: 30394984
[TBL] [Abstract][Full Text] [Related]
34. Proximal tumors are associated with greater mortality in colon cancer.
Wong R
J Gen Intern Med; 2010 Nov; 25(11):1157-63. PubMed ID: 20652758
[TBL] [Abstract][Full Text] [Related]
35. Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17.
Lee SHF; Abdul Rahman H; Abidin N; Ong SK; Leong E; Naing L
BMC Cancer; 2021 Apr; 21(1):477. PubMed ID: 33926405
[TBL] [Abstract][Full Text] [Related]
36. Uptake and outcomes of laparoscopically assisted resection for colon and rectal cancer in Australia: a population-based study.
Dobbins TA; Young JM; Solomon MJ
Dis Colon Rectum; 2014 Apr; 57(4):415-22. PubMed ID: 24608296
[TBL] [Abstract][Full Text] [Related]
37. Predictors of lymph node count in colorectal cancer resections: data from US nationwide prospective cohort studies.
Morikawa T; Tanaka N; Kuchiba A; Nosho K; Yamauchi M; Hornick JL; Swanson RS; Chan AT; Meyerhardt JA; Huttenhower C; Schrag D; Fuchs CS; Ogino S
Arch Surg; 2012 Aug; 147(8):715-23. PubMed ID: 22508672
[TBL] [Abstract][Full Text] [Related]
38. Site-specific associations between miRNA expression and survival in colorectal cancer cases.
Slattery ML; Herrick JS; Pellatt DF; Mullany LE; Stevens JR; Wolff E; Hoffman MD; Wolff RK; Samowitz W
Oncotarget; 2016 Sep; 7(37):60193-60205. PubMed ID: 27517623
[TBL] [Abstract][Full Text] [Related]
39. Distinct gene expression profiles of proximal and distal colorectal cancer: implications for cytotoxic and targeted therapy.
Maus MK; Hanna DL; Stephens CL; Astrow SH; Yang D; Grimminger PP; Loupakis F; Hsiang JH; Zeger G; Wakatsuki T; Barzi A; Lenz HJ
Pharmacogenomics J; 2015 Aug; 15(4):354-62. PubMed ID: 25532759
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]